Michael James Newman - 31 Jan 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
CSO and Director, Director, 10%+ Owner
Signature
/s/ Michael Newman
Issuer symbol
INDP
Transactions as of
31 Jan 2022
Net transactions value
-$100,043
Form type
4
Filing time
02 Feb 2022, 16:08:10 UTC
Previous filing
28 Jan 2022
Next filing
20 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INDP Common Stock Sale $29,351 -5,870 -0.42% $5.00 1,382,486 31 Jan 2022 See footnote F1, F2
transaction INDP Common Stock Sale $70,692 -14,130 -1% $5.00 1,368,356 01 Feb 2022 See footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares of common stock reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2021.
F2 Consists of (i) 1,355,654 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009.
F3 Consists of (i) 1,341,524 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009.